Coyle Financial Counsel’s Amgen AMGN Stock Holding History

Coyle Financial Counsel’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-59	Closed	-$11K	–	45
2018 Q2	$11K	Buy	+59	New	+$10.4K	0.01%	102

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Coyle Financial Counsel's AMGN Position: Q3 2018 in Review

Coyle Financial Counsel sold out of Amgen (AMGN) in Q3 2018, closing a stake of 59 shares — an estimated $11K sold.

Coyle Financial Counsel first reported a position in AMGN in Q2 2018 and held it in 1 quarter. The position peaked at $11K in Q2 2018. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

Coyle Financial Counsel reported no remaining Amgen position as of Q3 2018 after selling out during the quarter.
Coyle Financial Counsel sold 59 Amgen shares in Q3 2018, an estimated $11K.
Coyle Financial Counsel first reported a position in Amgen in Q2 2018 and held it in 1 quarter.
Coyle Financial Counsel's Amgen position peaked at $11K in Q2 2018.
1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on Coyle Financial Counsel's 13F filing for Q3 2018, filed 13 Nov 2018.